The public record · 119th Congress

OTC Monograph Drug User Fee Transparency Act

The Congressional Research Service has not published a summary of this measure.

Other titles

the names this measure carries besides the one at the top of this page, each with the record's own label for it. The collection includes titles given to parts of a bill as well as to the whole.

A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to transparency and reporting regarding over-the-counter drug monograph activities, and for other purposes.Official Title as Introduced

OTC Monograph Drug User Fee Transparency ActShort Title(s) as Introduced

Legislative history

S. 2513·Senate·Bill·Health

Sen. Tim Kaine(Democratic-Virginia)

Jul 29, 2025

SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Documents

Everything Congress printed about this measure. A bill is reprinted each time it changes, the Congressional Research Service summarizes each version, and the committee that reports a bill files its own written account of it.

Bill text

Jul 29, 2025As introduced in the Senate